Nivel 5 ATC
A10BJ06 - Semaglutide
44 medicamente în această clasă
Medicamente (20)
| Nume comercial | DCI | Concentrație | Producător |
|---|---|---|---|
| OZEMPIC 0,25 mg | Semaglutidum | 1,34mg/ml | Novo Nordisk a/S - Danemarca |
| OZEMPIC 0,5 mg | Semaglutidum | 1,34mg/ml | Novo Nordisk a/S - Danemarca |
| OZEMPIC 1 mg | Semaglutidum | 1,34mg/ml | Novo Nordisk a/S - Danemarca |
| OZEMPIC 2 mg | Semaglutidum | 2,68mg/ml | Novo Nordisk a/S - Danemarca |
| RYBELSUS 1,5 mg | Semaglutidum | 1,5mg | Novo Nordisk a/S - Danemarca |
| RYBELSUS 14 mg | Semaglutidum | 14mg | Novo Nordisk a/S - Danemarca |
| RYBELSUS 3 mg | Semaglutidum | 3mg | Novo Nordisk a/S - Danemarca |
| RYBELSUS 4 mg | Semaglutidum | 4mg | Novo Nordisk a/S - Danemarca |
| RYBELSUS 7 mg | Semaglutidum | 7mg | Novo Nordisk a/S - Danemarca |
| RYBELSUS 9 mg | Semaglutidum | 9mg | Novo Nordisk a/S - Danemarca |
| WEGOVY 0,25 mg | Semaglutidum | 0,25mg | Novo Nordisk a/S - Danemarca |
| WEGOVY 0,25 mg FLEXTOUCH | Semaglutidum | 0,25mg | Novo Nordisk a/S - Danemarca |
| WEGOVY 0,5 mg | Semaglutidum | 0,5mg | Novo Nordisk a/S - Danemarca |
| WEGOVY 0,5 mg FLEXTOUCH | Semaglutidum | 0,5mg | Novo Nordisk a/S - Danemarca |
| WEGOVY 1 mg | Semaglutidum | 1mg | Novo Nordisk a/S - Danemarca |
| WEGOVY 1 mg FLEXTOUCH | Semaglutidum | 1mg | Novo Nordisk a/S - Danemarca |
| WEGOVY 1,7 mg | Semaglutidum | 1,7mg | Novo Nordisk a/S - Danemarca |
| WEGOVY 1,7 mg FLEXTOUCH | Semaglutidum | 1,7mg | Novo Nordisk a/S - Danemarca |
| WEGOVY 2,4 mg | Semaglutidum | 2,4mg | Novo Nordisk a/S - Danemarca |
| WEGOVY 2,4 mg FLEXTOUCH | Semaglutidum | 2,4mg | Novo Nordisk a/S - Danemarca |
Substanțe active în A10BJ06
Proprietăți chimice
Sursă: PubChem (NIH) · CID 56843331
- Formula moleculară
- C187H291N45O59
- Greutate moleculară
- 4114 g/mol
- Număr CAS
- 910463-68-2
- InChIKey
- DLSWIYLPEUIQAV-CCUURXOWSA-N
- Denumire IUPAC
- 18-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]propanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[2-[[(2S)-5-carbamimidamido-1-(carboxymethylamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-18-oxooctadecanoic acid